Not designing with manufacturing in mind—even during early development—is a key reason fledgling biopharma companies fail.

Montreal-based Nomic Bio broadens its proteomics technology to offer a 1,000-plex protein measurement service.

Although not designed to eliminate experiments, the model, which is intended to accelerate process development, can reduce the number needed.

Results highlight importance of addressing overwork as an occupational health concern, and the need for workplace policies to ...

Cell and gene therapies offer potential new therapeutics but are currently constrained by complex and inefficient manufacturing strategies.

Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...

The treatment traps and neutralizes misfolded proteins to stop the progression of Alzheimer's disease and other neurodegenerative disorders.

In this Revvity GENCast episode 2, experts will discuss applications of gene editing to improve scientists’ understanding of the relationship between variant and disease in functional genomics studies ...

Mass photometry enables rapid, purification-free quantification of rAAV vectors, offering a faster solution for gene therapy manufacturing.

Whether you’re working in a startup, academic lab, or biopharma R&D team, this eBook offers a window into what’s working now and what’s possible next.

Nabla Bio's latest AI model update generates de novo antibodies for GPCRs with therapeutic-grade properties within a few ...

The project could eventually add more than 400 manufacturing jobs and over 1,500 construction jobs during site development.